PHT-776

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NamePHT-776
Drug Alias NameHPB-143PHT-776
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 degraders
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsInflammationAutoimmune DiseasesDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPolymed Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPhotys Therapeutics IncPolymed Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A